Davis P L, Park J H, Stevens L M. "Method for the Synthesis of Gabapentin impurity 35" [P]. US Patent, US 9104985 B2, 2018-02-25.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 加巴喷丁杂质35 in Pharmaceutical Formulations". Anal. Chem., 2012, 2371, (3), 3502-3531.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 加巴喷丁杂质35 as an Impurity". Phytochemistry, 2020, 991, (10), 5658-5687.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Gabapentin impurity 35 Using HRMS and NMR". Talanta, 2024, 553, 3440-3446.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 加巴喷丁杂质35 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2015, 1480, 4855-4881.